Biology and clinical implications of CD133(+) liver cancer stem cells.

Volume: 319, Issue: 2, Pages: 126 - 132
Published: Jan 15, 2013
Abstract
null null Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver, accounting for 80%–90% of all liver cancers. The disease ranks as the fifth most common cancer worldwide and is the third leading cause of all cancer-associated deaths. Although advances in HCC detection and treatment have increased the likelihood of a cure at early stages of the disease, HCC remains largely incurable because of late presentation...
Paper Details
Title
Biology and clinical implications of CD133(+) liver cancer stem cells.
Published Date
Jan 15, 2013
Volume
319
Issue
2
Pages
126 - 132
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.